{'text': 'AbbVie (ABBV) or Baxalta (BXLT): Which Is the Better Biopharma Investment Today?', 'publisher': {'href': 'https://www.thestreet.com', 'title': 'TheStreet'}, 'created_at': 'Fri, 21 Aug 2015 07:00:00 GMT', 'description': 'AbbVie (ABBV) or Baxalta (BXLT): Which Is the Better Biopharma Investment Today?  TheStreet', 'url': 'https://news.google.com/rss/articles/CBMiqwFBVV95cUxNVzA5QS1HQTVHTVVOWFNfdjV3UGh2N3FKM196S0k4bmpkMHVoNlZBWG9EMnRpeTNBeFpPcXU0bmVkRlZCVDJ3S0YwZloxajhrUmR5V0tCM3JCcVZHMW1ka0huczB2TXVDMEZrUWEzbS0yVmhJYmd3MGxFQlJtc0d5TTZxUm1nQ1ZBTGVIMVk2SEJUVGtDa2NNX2FIREFDc0hqWDdFTGFHUmZaXzA?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Blog: Fast-track FDA approval is for sale (and commanding top dollar)', 'publisher': {'href': 'https://www.modernhealthcare.com', 'title': 'Modern Healthcare'}, 'created_at': 'Thu, 20 Aug 2015 07:00:00 GMT', 'description': 'Blog: Fast-track FDA approval is for sale (and commanding top dollar)  Modern Healthcare', 'url': 'https://news.google.com/rss/articles/CBMiywFBVV95cUxNOUx6WDBPRmFhZDgyWWFXRDhzZE9VdHNYd0FDLVExSG80Q1loR2R2dlp4YWFNcHBNWXRqMEY5VEV6Y2EzWGpIRnBycHdudmtVN0lmMGEtUWpKQW81UTFPYnAzcTlSRG5nLWo5SG5OR0ZQeFJpV3NZTVJyZTdBU0JzcWJUQWE3Y2x5ME1nZVNGaE4wbmpJbERJR2tBVFE2NHBDaWdoMUFmcTJxY2pZY21HZE0wM1VrN0FNOXgyZXVpaEpTUU5kS0ZIS3lmbw?oc=5&hl=en-US&gl=US&ceid=US:en'}
